Roche Holding Ltd. (VTX:ROG) received a CHF 215 price target from investment analysts at HSBC Holdings plc in a research report issued to clients and investors on Tuesday, July 11th. The firm presently has a “sell” rating on the healthcare company’s stock.
Other research analysts have also issued reports about the stock. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on shares of Roche Holding and gave the stock a “buy” rating in a report on Saturday, May 20th. Jefferies Group LLC set a CHF 305 price objective on shares of Roche Holding and gave the stock a “buy” rating in a report on Saturday, May 20th. J P Morgan Chase & Co reissued a “buy” rating on shares of Roche Holding in a report on Wednesday, June 7th. UBS AG set a CHF 260 price objective on shares of Roche Holding and gave the stock a “neutral” rating in a report on Thursday, July 6th. Finally, Deutsche Bank AG set a CHF 260 price target on shares of Roche Holding and gave the stock a “neutral” rating in a research report on Friday, July 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of CHF 271.08.
Roche Holding (VTX ROG) traded down 0.08% during midday trading on Tuesday, hitting CHK 247.20. 1,045,421 shares of the stock traded hands. The company has a market cap of CHK 210.93 billion and a PE ratio of 21.95. The company’s 50-day moving average is CHK 246.12 and its 200-day moving average is CHK 251.76. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.